Jonathan M Lord

Summary

Affiliation: Peninsula Medical School
Country: UK

Publications

  1. pmc Metformin in polycystic ovary syndrome: systematic review and meta-analysis
    Jonathan M Lord
    Department of Endocrinology and Metabolism, Peninsula Medical School, South West Centre for Reproductive Medicine, Derriford Hospital, Plymouth, Devon, PL6 8DH
    BMJ 327:951-3. 2003
  2. ncbi request reprint Metformin in polycystic ovary syndrome
    Jonathan Lord
    Department of Obstetrics and Gynaecology, Peninsula Medical School, Royal Cornwall Hospital, Truro TR1 3LT, UK
    Curr Opin Obstet Gynecol 16:481-6. 2004
  3. ncbi request reprint The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome
    J Lord
    Department of Obstetrics and Gynaecology, Royal Cornwall Hospital, Truro, Cornwall, UK
    BJOG 113:1203-9. 2006
  4. ncbi request reprint The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial
    J Lord
    Department of Obstetrics and Gynaecology, Royal Cornwall Hospital, Truro, Cornwall, UK
    BJOG 113:817-24. 2006
  5. ncbi request reprint Polycystic ovary syndrome and fat distribution: the central issue?
    Jonathan Lord
    South West Centre for Reproductive Medicine, Derriford Hospital, Plymouth, Devon PL6 8DH, UK
    Hum Fertil (Camb) 5:67-71. 2002
  6. pmc Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount
    Jonathan M Lord
    BMJ 332:609. 2006

Collaborators

Detail Information

Publications6

  1. pmc Metformin in polycystic ovary syndrome: systematic review and meta-analysis
    Jonathan M Lord
    Department of Endocrinology and Metabolism, Peninsula Medical School, South West Centre for Reproductive Medicine, Derriford Hospital, Plymouth, Devon, PL6 8DH
    BMJ 327:951-3. 2003
    ..To assess the effectiveness of metformin in improving clinical and biochemical features of polycystic ovary syndrome...
  2. ncbi request reprint Metformin in polycystic ovary syndrome
    Jonathan Lord
    Department of Obstetrics and Gynaecology, Peninsula Medical School, Royal Cornwall Hospital, Truro TR1 3LT, UK
    Curr Opin Obstet Gynecol 16:481-6. 2004
    ..This review examines the recent literature in order to ascertain the evidence for the benefits and disadvantages of using metformin in women with polycystic ovary syndrome...
  3. ncbi request reprint The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome
    J Lord
    Department of Obstetrics and Gynaecology, Royal Cornwall Hospital, Truro, Cornwall, UK
    BJOG 113:1203-9. 2006
    ..To establish whether visceral fat mass is the most significant variable correlating with insulin resistance and other metabolic parameters in women with polycystic ovary syndrome (PCOS)...
  4. ncbi request reprint The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial
    J Lord
    Department of Obstetrics and Gynaecology, Royal Cornwall Hospital, Truro, Cornwall, UK
    BJOG 113:817-24. 2006
    ..To establish whether metformin has a significant action in reducing visceral fat and improving other metabolic parameters in women with polycystic ovary syndrome (PCOS)...
  5. ncbi request reprint Polycystic ovary syndrome and fat distribution: the central issue?
    Jonathan Lord
    South West Centre for Reproductive Medicine, Derriford Hospital, Plymouth, Devon PL6 8DH, UK
    Hum Fertil (Camb) 5:67-71. 2002
    ..Weight loss is an effective treatment even where there is only a very modest reduction. The key element in lifestyle modification is regular exercise...
  6. pmc Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount
    Jonathan M Lord
    BMJ 332:609. 2006